Apparently, AZ has production facilities in the EU that have not been approved by the EMA and therefore cannot produce vaccines there for the EU. They do use those facilities for production of vaccines for COVAX shipments. If the EMA approved those facilities the production capacity for EU destination vaccines would rise significantly.
Even if they create that spare vaccine capacity there are no guarantees that greater availability of AZ vaccine supplies will solve their problems following the continuous undermining of the AZ vaccine by most member states. It seems that no good deed goes unpunished in AZ's not for profit position, the EU childish position has undermined future cost effective vaccination for some of the COVAX poorest nations..
.Astrazeneca sacrificed over £21billion of revenues by selling its Covid vaccine at no profit, it emerged last night.The British company has pledged to produce 3billion doses of the life-saving jab it developed with Oxford University for an average price of just $5 (£3.60) globally – the minimum needed to recover costs. Its decision to forego huge profits is an unprecedented move by a multinational business, prompting the World Health Organisation to hail the jab as a ‘vaccine for the world’.
Last edited by JohnHarris; 26/03/21 12:10 AM.
